Animal study · Aging · 20 Nov 2026
In mice, raising FGF13 in astrocytes lined up with slower cognitive aging
Source: Aging Cell
What the research found
An Aging Cell paper, noted by Fight Aging on 20 November 2026, tracks fibroblast growth factor 13 in aging brain tissue. Public expression data showed FGF13 lower in aging mice and macaques, especially in the medial prefrontal cortex and in astrocytes. Switching the gene off in cortical astrocytes sped an aging pattern and hurt neurological function in mice. Putting extra FGF13 back delayed that pattern and eased aging-linked cognitive impairment in the same kind of experiment. RNA sequencing pointed to astrocyte inflammation and autophagy. The proposed mechanism is binding to Phafin2 and more autophagy in astrocytes, with less neuronal injury and less inflammatory release from microglia. That is a mouse gene study. It is not a human finding, and it does not name a dose. DOI 10.1111/acel.70784. Not medical advice.
Evidence level: Animal study. Results in animals or cells often don't carry over to people.
More aging news
- Mice without granzyme K kept more tissue function with age, while the usual age-related inflammation did not fall
- A Cambridge review gathers links between reading for pleasure and brain measures, and it does not show that reading prevents Alzheimer's
- In 253 older adults in Japan, a full intrinsic-capacity score lined up with frailty remission, not with staying robust
- In aged rats, Mboat1 lined up with Schwann cell senescence in the peripheral nerve
- A scoping review charted healthy-aging programs for adults with developmental disabilities